HomeBUSINESS
BUSINESS

Linzess Filed for Add’l Indication of Chronic Constipation: Astellas
(Sep.12.2017)

Astellas Pharma said on September 11 that it has submitted an application in Japan seeking an additional indication of chronic constipation for its guanylate cyclase-C receptor agonist Linzess (linaclotide) ...
(LOG IN FOR FULL STORY)

News Calendar